Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Distribution of paclitaxel and its precursors in different parts of Taxus wallichiana var. Mairei

View through CrossRef
To understand the distributions of paclitaxel and its precursors in the different parts of yew this study was conducted. The contents of paclitaxel and its precursors in the different parts of Taxus wallichiana var. mairei were determined with RP-HPLC. The contents of paclitaxel and its precursors in yew root are higher than those in other parts. The content of paclitaxel in the bark of Taxus wallichiana var. mairei is higher than that in leaf. But there was very little paclitaxel in the xylem and tender stem of Taxus wallichiana var. mairei. There were considerable paclitaxel precursors in the leaf of Taxus wallichiana var. mairei, but low contents in 2 - 3 years stem. The root of Taxus wallichiana var. mairei can be utilized also. It is reasonable measures of satisfying the demand of people on paclitaxel and preventting people cutting yew that artificially synthesize paclitaxel with the precursors extracted from yew leaf.
Title: Distribution of paclitaxel and its precursors in different parts of Taxus wallichiana var. Mairei
Description:
To understand the distributions of paclitaxel and its precursors in the different parts of yew this study was conducted.
The contents of paclitaxel and its precursors in the different parts of Taxus wallichiana var.
mairei were determined with RP-HPLC.
The contents of paclitaxel and its precursors in yew root are higher than those in other parts.
The content of paclitaxel in the bark of Taxus wallichiana var.
mairei is higher than that in leaf.
But there was very little paclitaxel in the xylem and tender stem of Taxus wallichiana var.
mairei.
There were considerable paclitaxel precursors in the leaf of Taxus wallichiana var.
mairei, but low contents in 2 - 3 years stem.
The root of Taxus wallichiana var.
mairei can be utilized also.
It is reasonable measures of satisfying the demand of people on paclitaxel and preventting people cutting yew that artificially synthesize paclitaxel with the precursors extracted from yew leaf.

Related Results

Vegetation of highly disturbed conifer forests around Murree, Pakistan
Vegetation of highly disturbed conifer forests around Murree, Pakistan
This phytosociological investigation is conducted in various disturbed forests around Murree hills. The main purpose of study is to explore community types, associated ground flora...
ANALISIS KETERKAITAN KEKERASAN DENGAN PERBUATAN CABUL TERHADAP ANAK
ANALISIS KETERKAITAN KEKERASAN DENGAN PERBUATAN CABUL TERHADAP ANAK
<span id="page3R_mcid85" class="markedContent"><em><span style="left: calc(var(--scale-factor)*85.10px); top: calc(var(--scale-factor)*399.05px); font-size: calc(var...
Abstract B8: Caveolae-mediated endocytosis is critical for tumor cell response to nab-paclitaxel
Abstract B8: Caveolae-mediated endocytosis is critical for tumor cell response to nab-paclitaxel
Abstract INTRODUCTION: Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States and is typified by poor outcomes. G...
Isolation of an endophytic fungus producing baccatin III from Taxus wallichiana var. mairei
Isolation of an endophytic fungus producing baccatin III from Taxus wallichiana var. mairei
Abstract The objective of this study was to isolate endophytic fungi producing baccatin III from yew for the purpose of baccatin III and paclitaxel manufacture. Surf...
Abstract B14: A novel strategy for the treatment of melanoma
Abstract B14: A novel strategy for the treatment of melanoma
Abstract Introduction: Approximately 76,000 individuals are diagnosed with melanoma, and about 9,000 die as a result of the disease each year in the United States. E...
A Taxane Total Cost of Care Analysis in Metastatic Breast Cancer: Results of Private Payor Claims Data.
A Taxane Total Cost of Care Analysis in Metastatic Breast Cancer: Results of Private Payor Claims Data.
Abstract Background: It has been estimated that over $8 billion is spent annually on the management of breast cancer in the US. The taxane chemotherapeutic agents ar...

Back to Top